By Stephanie Brown HealthDay ReporterMONDAY, Aug. 4, 2025 (HealthDay News) -- The U.S. Food and Drug Administration announced ...

Results from a small study suggest ketamine’s antidepressant effects may require activation of the brain’s opioid system.

The FDA is requiring opioid pain medication manufacturers to update safety labeling with a stronger emphasis on risks from ...

Federal officials plan to send warning letters to companies marketing products with 7-OH, part of effort to fight America's ...

Dr. Jerome Adams says that if federal funding falters, many people could lose access to care, reversing hard-earned gains ...

Launched in July 2024, a north shore drug task force has seen a growing collaboration among law enforcement agencies and an ...

In 2017, more than 2.2 million children were identified as having a parent navigating opioid use disorder. In Indiana, that ...

The U.S. Food and Drug Administration announced it will now be requiring updated safety labels for all opioid pain ...

Robert F. Kennedy Jr. discusses addiction and the opioid crisis, highlighting how availability can exacerbate the problem. He ...

Robert F. Kennedy Jr. addresses the opioid crisis, highlighting the staggering number of young American lives lost to ...

The city said the grant program will invest settlement funds in initiatives that support prevention, treatment, and recovery, ...

You'll get access to an ad-free website with a faster photo browser, the chance to claim free tickets to a host of events ...